慢性副鼻腔炎および鼻ポリープ（CRSwNP）の成人患者におけるデュピルマブ（デュピクセント®）治療の長期転帰を評価する研究

基本情報

NCT ID

NCT04959448

ステータス

実施中（募集終了）

試験のフェーズ

-

試験タイプ

観察

目標被験者数

717

治験依頼者名

Regeneron Pharmaceuticals

概要

The primary objectives of the study are: * To longitudinally characterize the long-term effectiveness of DUPIXENT® through assessment of patient-reported symptoms, Health-Related Quality of Life (HRQoL) related to Chronic rhinosinusitis with nasal polyposis (CRSwNP) and other type 2 comorbidities, and their change over-time. * To characterize patients who receive DUPIXENT® for CRSwNP in a real-world setting with respect to their medical history, demographic and disease characteristics, and type 2 comorbidities The secondary objectives of the study are: * To characterize real-world utilization of DUPIXENT® for patients with CRSwNP * To collect patient and physician global assessment of disease severity and treatment satisfaction for patients receiving DUPIXENT® for CRSwNP * To collect long-term safety data for patients receiving DUPIXENT® for CRSwNP

対象疾患

介入

依頼者（Sponsor）

実施施設 (7)